RB

Ravindranath Bhikaji Bagal

Active Director Designated Partner DIN 10002866
DIN 10002866 First appointment May 2022 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Ravindranath Bhikaji Bagal

Data last updated:

Ravindranath Bhikaji Bagal is a Designated Partner at Viansa Pharmaceuticals Llp (since 2022). The company operates in Paper.

DIN 10002866
Primary Designation Designated Partner
Industry Paper
First Appointment 23 May 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner23 May 20222022Active

Board colleagues of Ravindranath Bhikaji Bagal

NameDINCompanyDesignation
Santosh Kripashankar Mishra03047506Viansa Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Viansa Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Ravindranath Bhikaji Bagal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ravindranath Bhikaji Bagal

Ravindranath Bhikaji Bagal currently holds 1 directorship: Viansa Pharmaceuticals Llp (Designated Partner, since 23 May 2022).

Ravindranath Bhikaji Bagal was first appointed on 23 May 2022 as Designated Partner at Viansa Pharmaceuticals Llp.

The current boards of Ravindranath Bhikaji Bagal's companies include Santosh Kripashankar Mishra (Viansa Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available